| Literature DB >> 16626905 |
Nikolaos V Sipsas1, Joseph Papaparaskevas, Ioanna Stefanou, Konstantinos Kalatzis, Panayiotis Vlachoyiannopoulos, Athina Avlamis.
Abstract
We report a case of septic arthritis due to Roseomonas mucosa in a rheumatoid arthritis patient receiving infliximab therapy. This is the first report of septic arthritis due to R. mucosa, and infliximab therapy might be a predisposing factor because this infection was never reported in the pre-anti-tumor necrosis factor alpha therapy period.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16626905 DOI： 10.1016/j.diagmicrobio.2006.01.028
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN： 0732-8893 Impact factor: 2.803